Haisheng Peng

3.3k total citations · 1 hit paper
63 papers, 2.7k citations indexed

About

Haisheng Peng is a scholar working on Molecular Biology, Biomaterials and Biomedical Engineering. According to data from OpenAlex, Haisheng Peng has authored 63 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 25 papers in Biomaterials and 23 papers in Biomedical Engineering. Recurrent topics in Haisheng Peng's work include Nanoparticle-Based Drug Delivery (21 papers), RNA Interference and Gene Delivery (16 papers) and Nanoplatforms for cancer theranostics (14 papers). Haisheng Peng is often cited by papers focused on Nanoparticle-Based Drug Delivery (21 papers), RNA Interference and Gene Delivery (16 papers) and Nanoplatforms for cancer theranostics (14 papers). Haisheng Peng collaborates with scholars based in China, United States and Sweden. Haisheng Peng's co-authors include Qun Wang, Shu‐Kun Tang, Wenhua Li, Jinqiu Zhang, Cheng Xu, Xiaoying Liu, Man Zhao, Wenyuan Zhang, Minghui Li and Guangtian Wang and has published in prestigious journals such as Chemical Reviews, Chemical Society Reviews and PLoS ONE.

In The Last Decade

Haisheng Peng

61 papers receiving 2.6k citations

Hit Papers

Effects of polyethylene glycol on the surface of nanopart... 2021 2026 2022 2024 2021 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Haisheng Peng China 30 1.0k 960 872 359 334 63 2.7k
Yiping Hu China 10 1.1k 1.1× 991 1.0× 780 0.9× 461 1.3× 317 0.9× 22 2.5k
Zi‐Xian Liao Taiwan 24 879 0.9× 778 0.8× 1.0k 1.2× 328 0.9× 375 1.1× 42 2.4k
Michael Chorny United States 25 1.2k 1.1× 779 0.8× 891 1.0× 320 0.9× 356 1.1× 64 2.6k
Xiaoye Yang China 35 1.2k 1.2× 869 0.9× 1.3k 1.4× 385 1.1× 384 1.1× 90 3.0k
Yan Shen China 31 966 1.0× 992 1.0× 900 1.0× 328 0.9× 424 1.3× 114 2.6k
Hwa Seung Han South Korea 26 1.2k 1.2× 956 1.0× 1.4k 1.6× 499 1.4× 239 0.7× 40 3.0k
Hae Yun Nam South Korea 22 835 0.8× 1.1k 1.1× 497 0.6× 271 0.8× 272 0.8× 32 2.2k
Xinru You China 30 918 0.9× 900 0.9× 859 1.0× 314 0.9× 172 0.5× 61 2.4k
Young Tag Ko South Korea 33 932 0.9× 1.3k 1.3× 1.0k 1.2× 396 1.1× 425 1.3× 74 2.9k

Countries citing papers authored by Haisheng Peng

Since Specialization
Citations

This map shows the geographic impact of Haisheng Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haisheng Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haisheng Peng more than expected).

Fields of papers citing papers by Haisheng Peng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haisheng Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haisheng Peng. The network helps show where Haisheng Peng may publish in the future.

Co-authorship network of co-authors of Haisheng Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Haisheng Peng. A scholar is included among the top collaborators of Haisheng Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haisheng Peng. Haisheng Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lei, Lei, Wenbin Dai, Anlong Jiang, et al.. (2025). A pH‐Sensitive Nanosized Covalent–Organic Polymer for Enhanced Tumor Photodynamic Immunotherapy by Hypoxia Relief and STAT3 Inhibition. Advanced Science. 12(29). e04860–e04860. 4 indexed citations
2.
Guo, Zhanhu, Man Zhao, Wenyuan Zhang, et al.. (2025). Intelligent transdermal nanoparticles as synergizing advanced delivery systems for precision therapeutics. Materials Today Bio. 34. 102220–102220.
3.
Liu, Meilin, Jian Ding, Yanbo Peng, et al.. (2025). Platelet-rich plasma-contained drug delivery systems to treat orthopedic injuries. International Journal of Pharmaceutics X. 10. 100372–100372.
4.
Zhang, Wenyuan, Yang Liu, Yu Guo, et al.. (2024). Impaired cerebral microvascular endothelial cells integrity due to elevated dopamine in myasthenic model. Journal of Neuroinflammation. 21(1). 10–10. 3 indexed citations
5.
Peng, Haisheng, Bo Han, Xin Jin, et al.. (2024). 3D printing processes in precise drug delivery for personalized medicine. Biofabrication. 16(3). 32001–32001. 38 indexed citations
6.
Peng, Haisheng, Man Zhao, Xiaoying Liu, et al.. (2024). Biomimetic Materials to Fabricate Artificial Cells. Chemical Reviews. 124(23). 13178–13215. 12 indexed citations
7.
Xu, Shengnan, Wei Rao, Zhong Chen, et al.. (2022). Lipid droplet formation and dynamics: tracking by time-resolved fluorescence imaging. Materials Chemistry Frontiers. 6(24). 3691–3697. 8 indexed citations
8.
Zhang, Jinqiu, Man Zhao, Shu‐Kun Tang, et al.. (2021). Effects of polyethylene glycol on the surface of nanoparticles for targeted drug delivery. Nanoscale. 13(24). 10748–10764. 545 indexed citations breakdown →
9.
Chen, Zhong, Haisheng Peng, & Changmei Zhang. (2020). Advances in kidney-targeted drug delivery systems. International Journal of Pharmaceutics. 587. 119679–119679. 25 indexed citations
10.
Liao, Jian‐Hong, Haisheng Peng, Can Liu, et al.. (2020). Dual pH-responsive-charge-reversal micelle platform for enhanced anticancer therapy. Materials Science and Engineering C. 118. 111527–111527. 58 indexed citations
11.
Wang, Na, Wenyuan Zhang, Dandan Hu, et al.. (2020). ‘Prodrug-Like’ Acetylmannosamine Modified Liposomes Loaded With Arsenic Trioxide for the Treatment of Orthotopic Glioma in Mice. Journal of Pharmaceutical Sciences. 109(9). 2861–2873. 9 indexed citations
12.
Li, Lanying, Shu‐Kun Tang, Dandan Hu, et al.. (2019). Targeting Regulation of Dually Modified Liposomes by Polyethylene Glycol Length of Vesicle Surface. Journal of Biomedical Nanotechnology. 15(12). 2413–2427. 3 indexed citations
13.
Ren, Yachao, Jinxin Xie, Hui Yu, et al.. (2015). A new peptide ligand for colon cancer targeted delivery of micelles. Drug Delivery. 23(5). 1763–1772. 35 indexed citations
14.
Yu, Hui, et al.. (2014). Tamoxifen embedded in lipid bilayer improves the oncotarget of liposomal daunorubicin in vivo. Journal of Materials Chemistry B. 2(12). 1619–1619. 50 indexed citations
15.
Wang, Qun, Hao Cheng, Haisheng Peng, et al.. (2014). Non-genetic engineering of cells for drug delivery and cell-based therapy. Advanced Drug Delivery Reviews. 91. 125–140. 197 indexed citations
16.
Liu, Meifang, Minghui Li, Baoxin Li, et al.. (2014). The use of antibody modified liposomes loaded with AMO-1 to deliver oligonucleotides to ischemic myocardium for arrhythmia therapy. Biomaterials. 35(11). 3697–3707. 77 indexed citations
17.
Guo, Li, Yachao Ren, Bing Wang, et al.. (2014). Anti-apoptosis effect of polysaccharide isolated from the seeds of Cuscuta chinensis Lam on cardiomyocytes in aging rats. Molecular Biology Reports. 41(9). 6117–6124. 37 indexed citations
18.
Zhai, Dongxu, Qingfei Kong, Wangshu Xu, et al.. (2008). RAGE expression is up-regulated in human cerebral ischemia and pMCAO rats. Neuroscience Letters. 445(1). 117–121. 41 indexed citations
19.
Zhao, Wei, Dandan Wang, Bo Sun, et al.. (2008). TGF-β expression by allogeneic bone marrow stromal cells ameliorates diabetes in NOD mice through modulating the distribution of CD4+ T cell subsets. Cellular Immunology. 253(1-2). 23–30. 22 indexed citations
20.
Peng, Haisheng, Xijun Liu, Bo Sun, et al.. (2007). Voriconazole into PLGA nanoparticles: Improving agglomeration and antifungal efficacy. International Journal of Pharmaceutics. 352(1-2). 29–35. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026